Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23228
Title: Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
Austin Authors: O'Connor, Ellen ;Teh, Jiasian ;Kamat, Ashish M;Lawrentschuk, Nathan
Affiliation: Department of Urology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Issue Date: Jul-2020
metadata.dc.date: 2020-05-14
Publication information: Future oncology (London, England) 2020; 16(19): 1323-1325
URI: http://ahro.austin.org.au/austinjspui/handle/1/23228
DOI: 10.2217/fon-2020-0381
ORCID: 0000-0001-8553-5618
0000-0001-8576-586X
0000-0002-7882-5155
PubMed URL: 32406253
Type: Journal Article
Subjects: BCG vaccine
COVID-19
clinical trials
coronavirus
immunotherapy
mycobacterium bovis
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Dec 1, 2020

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.